Insulin treatment of elderly type 2 diabetic patients: Effects on retinopathy

Diabetes and Metabolism

Volumn 24, Issue 5, 1998, Pages 442-447

  Tovi, J ^a   Ingemansson, S O ^b   Engfeldt, P ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Elderly patients; Insulin treatment; Retinopathy; Type 2 diabetes

Indexed keywords

GLIBENCLAMIDE; GLIPIZIDE; INSULIN; ISOPHANE INSULIN;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; HUMAN; INSULIN TREATMENT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FASTING; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; RISK FACTORS; SULFONYLUREA COMPOUNDS;

EID: 0031673263     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Heaven CJ, Boase DL. Diabetic retinopathy. In : Shaw KM, eds. Diabetic complications. Chichester, England : John Wiley & Sons Ltd, 1996, 1-25.
2. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiology Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol, 1984, 102, 527-532.
3. Aldington SJ, Stratton IM, Holman RR, Matthews DR, Turner RC, Kohner EM. Nine-year status of diabetic retinopathy and photocoagulation in the UK prospective diabetes study. Diabetologia, 1996, 39 (Suppl. 1), 90.
4. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA, 1988, 260, 2864-2871.
5. Klein R, Klein BEK, Moss SE. Epidemiology of proliferative diabetic retinopathy. Diabetes Care, 1992, 15, 1875-1891.
6. Cahill M, Halley A, Codd M, et al. Prevalence of diabetic retinopathy in patients with diabetes mellitus diagnosed after the age of 70 years. Br J Ophthalmol, 1997, 81, 218-222.
7. Hirvelä H. Diabetic retinopathy in people aged 70 years or older. The Oulu Eye Study. Br J Ophthalmol, 1997, 81, 214-217.
8. Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet, 1993, 341, 1306-1309.
9. Reichard P, Nilsson B-Y. Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellilus. N Engl J Med, 1993, 329 (5), 304-309.
10. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-986.
11. Henricsson M, Janzon L, Groop L. Progression of retinopathy after change of treatment from oral antihyperglycemic agents to insulin in patients with NIDDM. Diabetes Care, 1995, 18, 1571-1576.
12. Henricsson M, Nilsson A, Janzon L, Groop L. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus. Diabetic Med, 1997, 14, 124-131.
13. Tovi J, Furhoff A-K, Lennerhagen P, Engfeldt P. Starting insulin therapy in elderly non-insulin-dependent diabetic patients at a health care centre. Methodological and economic aspects. Scand J Health-Care, 1997, 15, 87-91.
14. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiology Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol, 1989, 107, 237-243.
15. Klein R, Klein BEK, Magli YL, et al. An alternative method of grading diabetic retinopathy. Ophthalmology, 1986, 93, 1183-1187.
16. Henricsson M, Tyrberg M, Heijl A. Incidence of blindness and visual impairment in diabetic patients participating in an ophthalmological control and screening programme. Acta Ophthalmol Scand, 1996, 74, 533-538.
17. Klein R, Klein BEK, Moss SE. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med, 1996, 124 (1 pt 2), 90-96.
18. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus : A randomized prospective 6-year study. Diabetes Res Clin Pract, 1995, 28/2, 103-117.
19. Klein R, Klein B, Moss S, Cruickshanks K. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med, 1994, 154, 2169-2178.
20. The Diabetes Control and Complications Trial Group. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol, 1995, 113, 36-51.
21. Agardh C-D, Eckert B, Agardh E. Irreversible progression of severe retinopathy in young type 1 insulin-dependent diabetes mellitus patients after improved metabolic control. J Diabetes Complications, 1992, 6, 96-100.
22. Chantelau E, Kohner EM. Why some cases of retinopathy worsen when diabetic control improves. BMJ, 1997, 315, 1105-1106.
23. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiology Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol, 1989, 107, 244-249.
24. Chaturvedi N, Stephenson JM, Fuller JH. The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study. Diab Care, 1995, 18, 785-792.
25. Moss SE, Klein R, Klein BE, Cigarette smoking and ten-year progression of diabetic retinopathy. Ophthalmology, 1996, 103, 1438-1442.